Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jourdan A Andersson

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
NPJ Vaccines|January 30, 2021
A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platformPaul B Kilgore, Jian Sha, Jourdan A Andersson, et al.
NPJ Vaccines|December 22, 2017
Immunisation of two rodent species with new live-attenuated mutants of <i>Yersinia pestis</i> CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plagueBethany L Tiner, Jian Sha, Yingzi Cong, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2017
Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic TherapeuticsJourdan A Andersson, Jian Sha, Michelle L Kirtley, et al.
Msphere|December 17, 2016
New Insights into Autoinducer-2 Signaling as a Virulence Regulator in a Mouse Model of Pneumonic PlagueEric C Fitts, Jourdan A Andersson, Michelle L Kirtley, et al.
Frontiers in Cellular and Infection Microbiology|November 2, 2017
Identification of New Virulence Factors and Vaccine Candidates for <i>Yersinia pestis</i>Jourdan A Andersson, Jian Sha, Tatiana E Erova, et al.
Infection and Immunity|March 11, 2015
High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infectionDuraisamy Ponnusamy, Eric C Fitts, Jian Sha, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2019
T6SS and ExoA of flesh-eating <i>Aeromonas hydrophila</i> in peritonitis and necrotizing fasciitis during mono- and polymicrobial infectionsAna Fernández-Bravo, Paul B Kilgore, Jourdan A Andersson, et al.
Mbio|March 12, 2020
New Host-Directed Therapeutics for the Treatment of Clostridioides difficile InfectionJourdan A Andersson, Alex G Peniche, Cristi L Galindo, et al.
Frontiers in Cellular and Infection Microbiology|November 29, 2016
Protective Immunity Elicited by Oral Immunization of Mice with <i>Salmonella enterica</i> Serovar Typhimurium Braun Lipoprotein (Lpp) and Acetyltransferase (MsbB) MutantsTatiana E Erova, Michelle L Kirtley, Eric C Fitts, et al.
Frontiers in Immunology|July 12, 2017
A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, <i>Bacillus anthracis</i> and <i>Yersinia pestis</i>Pan Tao, Marthandan Mahalingam, Jingen Zhu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
NPJ Vaccines|January 30, 2021
A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platformPaul B Kilgore, Jian Sha, Jourdan A Andersson, et al.
NPJ Vaccines|December 22, 2017
Immunisation of two rodent species with new live-attenuated mutants of <i>Yersinia pestis</i> CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plagueBethany L Tiner, Jian Sha, Yingzi Cong, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2017
Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic TherapeuticsJourdan A Andersson, Jian Sha, Michelle L Kirtley, et al.
Msphere|December 17, 2016
New Insights into Autoinducer-2 Signaling as a Virulence Regulator in a Mouse Model of Pneumonic PlagueEric C Fitts, Jourdan A Andersson, Michelle L Kirtley, et al.
Frontiers in Cellular and Infection Microbiology|November 2, 2017
Identification of New Virulence Factors and Vaccine Candidates for <i>Yersinia pestis</i>Jourdan A Andersson, Jian Sha, Tatiana E Erova, et al.
Infection and Immunity|March 11, 2015
High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infectionDuraisamy Ponnusamy, Eric C Fitts, Jian Sha, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2019
T6SS and ExoA of flesh-eating <i>Aeromonas hydrophila</i> in peritonitis and necrotizing fasciitis during mono- and polymicrobial infectionsAna Fernández-Bravo, Paul B Kilgore, Jourdan A Andersson, et al.
Mbio|March 12, 2020
New Host-Directed Therapeutics for the Treatment of Clostridioides difficile InfectionJourdan A Andersson, Alex G Peniche, Cristi L Galindo, et al.
Frontiers in Cellular and Infection Microbiology|November 29, 2016
Protective Immunity Elicited by Oral Immunization of Mice with <i>Salmonella enterica</i> Serovar Typhimurium Braun Lipoprotein (Lpp) and Acetyltransferase (MsbB) MutantsTatiana E Erova, Michelle L Kirtley, Eric C Fitts, et al.
Frontiers in Immunology|July 12, 2017
A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, <i>Bacillus anthracis</i> and <i>Yersinia pestis</i>Pan Tao, Marthandan Mahalingam, Jingen Zhu, et al.
Pageof 2